Electronegative low density lipoprotein subform is increased in patients with short-duration IDDM and is closely related to glycaemic control

Diabetologia

Volumn 39, Issue 12, 1996, Pages 1469-1476

  Sanchez Quesada J L ^a   Perez A ^a   Caixas A ^a   Ordonmez Llanos J ^a,b   Carreras, G ^a   Payes A ^a   Gonzalez Sastre F ^a,b   De Leiva, A ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

electronegative LDL; glycaemic control; insulin dependent diabetes mellitus; intensive insulin therapy; LDL oxidation; LDL subfraction phenotype

Indexed keywords

INSULIN; LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; OXIDATION; PHENOTYPE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CHROMATOGRAPHY, GEL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INSULIN; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATION-REDUCTION; REFERENCE VALUES;

EID: 0029961240     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050600     Document Type: Article

References (57)

1. Pyörälä K, Laakso M, Uusitupa M (1987) Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 3: 463-524
2. Assmann G, Schulte H (1988) The prospective cardiovascular Munster (PROCAM) study: Prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J 116: 1713-1724
3. Brown MS, Goldstein JL (1976) Familial hypercholesterolemia: a genetic defect in the low density lipoprotein receptor. N Engl J Med 294: 1386-1390
4. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB (1986) Incidence of coronary heart disease and lipoprotein cholesterol: the Framingham Heart Study. JAMA256: 2835-2838
5. The DCCT Research Group (1992) Lipid and lipoprotein levels in patients with insulin-dependent diabetes mellitus: the Diabetes Control and Complications Trial (DCCT) experience. Diabetes Care 15: 886-894
6. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Beyond cholesterol. Modifications of low density lipoprotein that increase its atherogenicity. N Engl J Med 320: 915-924
7. Lyons TJ, Klein RL, Baynes JW, Stevenson HC, Lopes-Virella MS (1987) Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by low density lipoproteins from type 1 (insulin-dependent) diabetic patients: The influence of non-enzymatic glycosylation of low density lipoprotein. Diabetologia 30: 916-923
8. Wolff SP, Dean RT (1987) Glucose autoxidation and protein modification: the potential role of autoxidative glycosylation in diabetes mellitus. Biochem J 245: 243-250
9. Sato Y, Hotta N Sakamoto N, Matsuoka S, Ohishi N, Yagi K (1979) Lipid peroxide level in plasma of diabetic patients. Biochem Med 21: 104-107
10. Stringer MD, Gorog PG, Freeman A, Kakkar VV (1989) Lipid peroxides and atherosclerosis. BMJ 298: 281-284
11. Bellomo G, Maggi E, Poli M, Agosta FG, Bollati P, Finardi G (1995) Autoantibodies against oxidatively modified low density lipoproteins in NIDDM. Diabetes 44: 60-66
12. Bowie A, Owens D, Collins P, Johnson A, Tomkin GH (1993) Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient? Atherosclerosis 102: 63-67
13. Babiy AV, Gebicki JM, Sullivan DR, Willey K (1992) Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation. Biochem Pharmacology 43: 995-1000
14. Dimitriadis E, Griffin M, Owens D, Johnson A, Collins P, Tomkin GH (1995) Oxidation of low density lipoprotein in NIDDM:its relationship to fatty acid composition. Diabetologia 38: 1300-1306
15. Tsai EC, Hirsch IB, Brunzell JD, Chait A (1994) Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 43: 1010-1014
16. Beaudeux JL, Guilauseau PJ, Peynet J et al. (1995) Enhanced susceptibility of low-density lipoprotein to in vitro oxidation in type 1 and type 2 diabetic patients. Clin Chim Acta 239: 131-141
17. Cominacini L, Garbin U, Pastorino AM et al. (1994) Increased susceptibility of LDL to in vitro oxidation in patients with insulin-dependent and non-insulin-dependent diabetes mellitus. Diabetes Res 26: 173-184
18. Rabini RA, Fumelli P, Galassi R, Dousset N, Taus M, Ferretti G, Mazzanti L, Curatola G, Solèra ML, Valdiguié P (1994) Increased susceptibility to lipid oxidation of low density lipoproteins and erythrocyte membranes from diabetic patients. Metabolism 43: 1470-1474
19. Reaven PD, Barnett J, Herold DA, Edelman S (1995) Effects of vitamin E on susceptibility of low-denstity lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glycation in NIDDM. Diabetes Care 18: 807-816
20. Taus M, Ferretti G, Curatola G, Dousset N, Solèra ML, Valdiguié P (1992) Lower susceptibility of low density lipoprotein to in vitro oxidation in diabetic patients. Biochem Int 28: 835-842
21. Gugliucci A, Menini T, Stahl AJ (1994) Susceptibility to copper-enhanced autoxidation of VLDL + LDL fractions from diabetic patients. Biochem Mol Biol Int 32: 139-147
22. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willet WC, Krauss RM (1988) Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 13: 1917-1921
23. James RW, Pometta D (1990) Differences in lipoprotein subfraction composition and distribution between type 1 diabetic men and control subjects. Diabetes 39: 1158-1164
24. James RW, Pometta D (1991) The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients. Diabetologia 34: 246-252
25. Feingold KR, Grunfeld C, Pang M, Doerrler W, Krauss RM (1992) LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. Arteriosclerosis Thrombi 2: 1496-1502
26. de Graaf J, Hak-Lemmers HLM, Hectors MPC, Demacker PNM, Hendriks JCM, Stalenhoef AFH (1991) Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arteriosclerosis 11: 298-306
27. Avogaro P, Bittolo Bon G, Cazzolato G (1988) Presence of a modified low density lipoprotein in humans. Arteriosclerosis 8: 79-87
28. Cazzolato G, Avogaro P, Bittolo-Bon G (1991) Characterization of an more electronegative charged LDL subfraction by ion exchange HPLC. Free Rad Biol Med 11: 247-253
29. Hodis HN, Kramsch DM, Avogaro P et al. (1994) Biochemical and citotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL-). J Lipid Res 35: 669-677
30. Shimano H, Yamada N, Ishibashi S et al. (1991) Oxidationlabile subfraction of human plasma low density lipoprotein isolated by ion-exchange chromatography. J Lipid Res 32: 763-773
31. Demuth K, Myara I, Chappey B, Vedie B, Moatti N (1995) Electronegative LDL subfraction isolated from human plasma by anion exchange FPLC is not an oxidized LDL subfraction. Atherosclerosis 115[Suppl]:S75 (Abstract)
32. Hodis NH, Kramsch DM, Sevanian A et al. (1991) Correlation between circulating modified low density lipoprotein and severity of atherosclerosis. Clin Res 39: 399A (Abstract)
33. National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039-1057
34. nd) National, Heart, Lung and Blood Institute, Bethesda, MD (US Government Printing Office No. 1982-361-132: 678). HHW Publication No. (NIH): 75-628 (revised)
35. Bradford MA (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye-binding. Anal Biochem 72: 248-254
36. Havel RJ, Eder HA, Bragdon JH (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345-1353
37. Vedie B, Myara I, Pech MA, Maziere JC, Maziere C, Caprani A, Moatti N (1991) Fractionation of charge-modified low density lipoprotein by fast protein liquid chromatography. J Lipid Res 32: 1359-1369
38. Sánchez-Quesada JL, Homs-Serradesanferm R, Serrat-Serrat J, Serra-Grima JR, Gonźalez-Sastre F, Ordónmez-Llanos J (1995) Increase of LDL susceptibility to oxidation occurring after intense, long duration aerobic exercise. Atherosclerosis 118: 297-305
39. Esterbauer H, Striegl G, Puhl H, Rothender M (1989) Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Commun 6: 67-75
40. Griffin BA, Caslake MJ, Yip B, Tait GW, Packard CJ, Shepherd J (1990) Rapid isolation of low density lipoprotein subfractions from plasma by density gradient ultracentrifugation. Atherosclerosis 83: 59-67
41. Austin MA, King MC, Vranizan KM, Newman B, Krauss RM (1988) Inheritance of low-density subclass patterns: results of complex segregation analysis. Am J Hum Genet 43: 838-846
42. Krauss RM, Burke DJ (1982) Identification of multiple LDL subclasses of plasma lipoproteins in normal humans. J Lipid Res 23: 97-103
43. Lesnik P, Vonica A, Guerin M, Moreau M, Champman MJ (1993) Anticoagulant activity of tissue factor pathway inhibitor in human plasma is preferentially associated with dense subspecies of LDL and HDL and with Lp(a). Arterioscl Thromb 13: 1066-1075
44. Jay Smith S, Cooper GR, Myers GL, Sampson EJ (1993) Biological variability in concentrations of serum lipids: sources of variation among results from published studies and composite predicted values. Clin Chem 39: 1012-1022
45. Bagdade JD, Helve E, Taskinen MR (1991) Effects of continuous insulin infusion therapy on lipoprotein surface and core lipid composition in insulin-dependent diabetes mellitus. Metabolism 40: 445-449
46. Leonhardt W, Hanefeld M, Müller G et al. (1995) Impact of concentration of glycosilated hemoglobin on the lag time of oxidizability of low density lipoproteins. Atherosclerosis 115:S23 (Abstract)
47. Julier K, Dean JD, Mackness MI, Durrington PN (1995) Susceptibility of low and high density lipoproteins from subjects with diabetes to in vitro oxidative modification. Atherosclerosis 115:S23 (Abstract)
48. Lyons TJ (1991) Oxidized low density lipoproteins: a role in the pathogenesis of atherosclerosis in diabetes? Diabetes Care 8: 411-419
49. Brownlee M, Vlassara H, Cerami A (1985) Non-enzymatic glycosylation products on collagen covalently trap low density lipoprotein. Diabetes 34: 938-941
50. Walzem RL, Watkins S, Frankel EN, Hansen RJ, German JB (1995) Older plasma lipoproteins are more susceptible to oxidation: a linking mechanism for the lipid and oxidation theories of atherosclerotic cardiovascular disease. Proc Natl Acad Sci USA 92: 7460-7464
51. Steinbrecher UP, Witztum JL (1984) Glucosylation of low density lipoproteins to an extent comparable to that seen in Diabetes slows their catabolism. 33: 130-134
52. Makino K, Furbee JW, Scanu AM, Fless GM (1995) Effect of glycation on the properties of lipoprotein (a). Arterioscl Thomb Vasc Biol 15: 385-391
53. Gugluicci-Creriche A, Stahl AJC (1993) Glycation and oxidation of human low density lipoproteins reduces heparin binding and modifies charge. Scand J Clin Lab Invest 53: 125-132
54. Tertov VV, Sobenin IA, Tonevitsky AG, Orekhov AN, Smirnov VN (1990) Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: separation from native lipoprotein by affinity chromatography. Biochem Biophys Res Commun 167: 1122-1130
55. Winocour PH, Durrington PN, Bhatnagar D, Ishola M, Arrol S, Mackness M (1992) Abnormalities of VLDL, IDL and LDL characterize insulin-dependent diabetes mellitus. Arterioscler Thromb 12: 920-928
56. Parthasarathy S, Satanam N (1994) Mechanisms of oxidation, antioxidants, and atherosclerosis. Curr Opin Lipidol 5: 371-375
57. Ruotolo G, Parlavecchia M, Taskinen MR, Galimberti G, Zoppo A, Le NA (1994) Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Diabetes Care 17: 6-12